NCT04539340View on ClinicalTrials.gov

A Multi-cohort Study of the Tolerance, Safety, and Pharmacokinetics of GNR-055 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 28, 2020

Primary Completion Date

September 8, 2020

Study Completion Date

September 8, 2020

Conditions
Mucopolysaccharidosis Type IIMetabolic Diseases
Interventions
BIOLOGICAL

GNR-055

Single intravenous administration

Trial Locations (1)

119991

"FSAEI HE I.M. Sechenov First Moscow State Medical University of the Ministry of Health of Russian Federation", Moscow

All Listed Sponsors
lead

AO GENERIUM

INDUSTRY

NCT04539340 - A Multi-cohort Study of the Tolerance, Safety, and Pharmacokinetics of GNR-055 in Healthy Volunteers | Biotech Hunter | Biotech Hunter